Endoscopic Ultrasound-Guided Hepatogastrostomy (EUS-HGS) as a Rescue Biliary Drainage Strategy: Experience in a Tertiary Care Hospital in Costa Rica.

Introduction: Endoscopic retrograde cholangiopancreatography (ERCP) is the standard treatment for biliary drainage, but it may fail in patients with advanced malignant obstruction. In such cases, endoscopic ultrasound-guided hepatogastrostomy (EUS-HGS) has emerged as an effective therapeutic alterna...

Descripción completa

Detalles Bibliográficos
Autores: Evans Rodríguez, Enrique, Araya Acero, Luis Carlos, Vargas Madrigal, Jorge Eduardo
Tipo de recurso: artículo
Estado:Versión publicada
Fecha de publicación:2025
País:Perú
Institución:Sociedad de Gastroenterología del Perú
Repositorio:Revista de Gastroenterología del Perú
Idioma:español
OAI Identifier:oai:ojs.revistagastroperu.com:article/1928
Acceso en línea:https://revistagastroperu.com/index.php/rgp/article/view/1928
Access Level:acceso abierto
Palabra clave:Colangiopancreatografia Retrógrada Endoscópica
Obstrucción Duodenal
Conductos Biliares
Cholangiopancreatography, Endoscopic Retrograde
Duodenal Obstruction
Bile Ducts
Descripción
Sumario:Introduction: Endoscopic retrograde cholangiopancreatography (ERCP) is the standard treatment for biliary drainage, but it may fail in patients with advanced malignant obstruction. In such cases, endoscopic ultrasound-guided hepatogastrostomy (EUS-HGS) has emerged as an effective therapeutic alternative. This retrospective study describes the experience of Hospital San Juan de Dios, Costa Rica, with EUS-HGS as a rescue drainage strategy after failed ERCP. Objective: To describe the institutional experience with EUS-HGS as a biliary drainage technique in patients with unresectable malignant obstruction and failed ERCP, evaluating its technical feasibility, clinical efficacy, and safety in a high-complexity public center. Materials and Methods: Twenty consecutive patients treated with EUSHGS between April 2023 and March 2024 were included. Clinical success was defined as a ≥50% reduction in total bilirubin at 30 days. Adverse events, procedure time, and technical success were evaluated. Results: Technical success was achieved in 100% of cases (20/20). Nineteen patients (95%) reached clinical success. The mean procedure time was 18 minutes. No major complications or mortality were reported. Three patients (15%) presented mild adverse events (abdominal pain and minimal bleeding). Conclusion: EUS-HGS proved to be a safe, effective, and reproducible technique in patients with failed ERCP. The institutional experience supports its use in public centers with trained personnel, strengthening its role in the management of complex malignant biliary obstruction.